A Synthetic Genetic Platform to Deliver Higher Precision Care for Recurrent or Refractory Cancers with Wnt Pathway Activation - Andy Hill CARE Fund

Browse All Past Grants

A Synthetic Genetic Platform to Deliver Higher Precision Care for Recurrent or Refractory Cancers with Wnt Pathway Activation

Grant Information

Funding Opportunity	Breakthrough Seed Funding
Funding Cycle	Cycle 1
Award Date	May 2023
Institution / Organization	University of Washington
Principal Investigator(s)	Jennifer Nemhauser, PhD

Questions about Grants?

Please contact CARE Fund with any feedback or questions you have regarding CARE Fund grant programs or the application process.

Contact CARE Fund